## **Core Concept**
The patient in this scenario is on phenytoin, an antiepileptic medication, and develops depression for which tricyclic antidepressants (TCAs) are prescribed. The patient now presents with symptoms of lassitude and a significantly low hemoglobin (Hb) level of 8 gm/dl, suggesting anemia. The interaction between these medications and the development of anemia needs to be considered.

## **Why the Correct Answer is Right**
The correct approach involves considering the potential cause of anemia in this patient, which could be related to the medications he is taking. Phenytoin can cause megaloblastic anemia due to its interference with folate metabolism. TCAs can also contribute to or exacerbate existing conditions but are less directly linked to anemia. The management of this patient would involve checking for folate and vitamin B12 deficiencies, as these are common causes of megaloblastic anemia, especially in the context of phenytoin therapy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, without specifying the cause of anemia, merely prescribing iron or other supplements might not address the underlying issue, which could be related to folate or vitamin B12 deficiency.
- **Option B:** Similarly, this option does not address the potential underlying cause of the anemia and assumes a specific etiology (e.g., iron deficiency) without investigation.
- **Option D:** This option might seem plausible but stopping the TCA does not necessarily address the cause of the anemia, and the anemia itself needs to be investigated and managed.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that patients on long-term antiepileptic drugs like phenytoin should have regular monitoring of their blood counts and folate levels, as these drugs can interfere with folate metabolism, leading to megaloblastic anemia.

## **Correct Answer:** C.